Search for: "PROFESSIONAL DRUG COMPANY, INC." Results 661 - 680 of 721
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jun 2010, 8:16 am by law shucks
Professional Profile John Desmarais is Of Counsel to the law firm of Kirkland & Ellis LLP. [read post]
21 Aug 2015, 11:24 am by Cynthia Marcotte Stamer
Employers sponsoring health plans and members of their management named as plan fiduciaries or otherwise having input or oversight over the health plan should verify their company’s group health plan meets the out-of-pocket maximum rules of the Patient Protection and Affordable Care Act (ACA) § 1302(c)(1) as well as a long list of other federal health benefit rules to minimize the risk that violations will compel the sponsoring employer to self-assess, self-report on IRS Form… [read post]
21 Jan 2023, 6:07 pm by admin
Several lawsuits have been filed against cosmetic hair relaxer companies since the release of the October 2022 NIH study. [read post]
25 May 2012, 3:13 pm by Cynthia Marcotte Stamer
  Recognized in Who’s Who In American Professionals and both an American Bar Association (ABA) and a State Bar of Texas Fellow, Ms. [read post]
14 Nov 2017, 3:27 am by Kevin LaCroix
  PART ONE: BACKGROUND   Understanding cryptocurrency and ICOs remains a challenge for even the most seasoned financial professionals and legal scholars. [read post]
21 Sep 2011, 3:05 pm by Law Lady
Cathy Vice's negligent-admission claims against Elmcroft of Hendersonville do not allege medical malpractice because there is no evidence that the facility relied on a medical professional's assessment when it admitted Vice's mother, the three-judge panel said. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
6 May 2007, 7:21 pm
The title company or your lawyer has a copy. [read post]
24 Apr 2015, 7:29 am by John Elwood
¯\_(ツ)_/¯ The respondent in Spokeo, Inc. v. [read post]
12 Jan 2015, 10:09 am by The Public Employment Law Press
DeRosa served as the Director of Communications and Legislation for Cordo and Company, an Albany based government affairs firm. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from… [read post]
27 Aug 2011, 4:34 am
Decisions of interest involving Government and Administrative Law Source: Justia August 26, 2011  Dickow v. [read post]
9 Jun 2018, 11:15 am by Schachtman
Group, Inc., 639 F.3d 11 (1st Cir. 2011). [read post]
10 Nov 2023, 1:35 pm by Cynthia Marcotte Stamer
quickly to implement and communicate 2024 health spending account (“HFSA”), high deductible health plan amounts relevant to determining eligibility to contribute to a medical savings account (“MSA”), adoption credit and exclusion limits, and other inflation-adjusted limitations relevant to the annual enrollment, withholding and other year-end tax and benefit planning of workers and their families to assist workers to take into account these adjustments during 2024 benefit… [read post]